Hi everyone! We wanted to take a moment to introduce ourselves to give you a better idea of who we are and what we do 🧠

🎉 Exciting news! Dr. Thomas Karikari has been named one of Nature’s Three Rising Stars in Ageing Research for his groundbreaking work on blood-based biomarkers for Alzheimer’s disease. 🧠 👉 Read more: https://t.co/Kk4L8Gwisk #Neuroscience #Alzheimers #AgeingResearch

Our PI, Dr. Thomas K. Karikari, PhD, delivered a keynote at the ARGOnaut Club Voyager Summit 2025, highlighting innovations in biofluid biomarkers for Alzheimer’s disease. Proud of our team, James Emmanuel & Marissa Farinas for representing the #KarikariLab with excellence!

Excited to share the inspiring journey of Dr Yijun Chen, whose work at the intersection of engineering and clinical science is advancing Alzheimer’s disease research. From his biomedical engineering background and industry experience to pioneering innovative blood-based biomarker

🚨 Exciting news! 🚨 @TommyKakari, along with a group of experts, has just helped create the Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings This

🚨 Final Day at #AAIC2025 - Karikari Lab Poster Highlights! It’s hard to believe we’re already wrapping up our in-person time at the Alzheimer’s Association International Conference 2025! We have had an incredible week sharing ideas, connecting with colleagues, and presenting

🎉 Proud to share that Karikari Lab just published insightful collaborative research showing how plasma biomarkers can detect Alzheimer’s related brain changes in people without dementia! The study highlights the power of blood tests like p-tau217 and NfL to identify early signs

🚨 #AAIC2025 Virtual Presenters – Karikari Lab Spotlight! We’re excited to share the amazing work of our virtual presenters at the Alzheimer’s Association International Conference 2025! You can explore impactful research from the Karikari Lab including studies on blood

🚨 Featuring Day 3 Highlights from the Karikari Lab at #AAIC2025! We are thrilled to bring you more frontier research from Karikari Lab at the Alzheimer's Association International Conference 2025 (#AAIC25)! Today, the discussion revolves around novel approaches of biomarker

📍Day 2 at #AAIC2025 — The Karikari Lab continues to shine! Catch two exciting posters today: 🔹 Dr. Xuemei Zeng – Poster #322 "Plasma biomarkers predict incident cognitive decline up to 29 years prior to disease onset: a memory clinic cohort study of 4,073 participants". 🔹 Dr.

We’re kicking things off this Sunday with groundbreaking Alzheimer’s research from our incredible team at Karikari Lab! 💙 This week at Alzheimer's Association International Conference (AAIC25), our researchers will be showcasing their work through poster and oral presentations,

We are delighted to present our new blood-based p-tau217 biomarker assay developed in the Karikari Lab at the University of Pittsburgh!!!🎉. In addition to analytical validation, we benchmarked the performance of the new method against commercial p-tau217, showing similar

🚨 New Publication Alert! 🚨 Our lab shows plasma and serum are equivalent for measuring p-tau217, a promising biomarker for Alzheimer's disease and other neurodegenerative diseases, using four blood-based assays. Read more 👉 https://t.co/jAKeDhytE3 #Alzheimers #Biomarkers

⏰ Happening TOMORROW! Don’t miss Dr. Thomas Karikari’s Senior Vice Chancellor Research Seminar on breaking barriers to Alzheimer’s diagnosis. 🧠 Read this timely @PittHealthSci feature now and join us to learn how we’re advancing dementia detection! #Alzheimers #PittResearch

🎉 Proud moment for our team at the Pitt Psychiatry Annual Research Day! 🏆 3 Top Poster Awards won: 1) Michel N Nafash & Lamia T Choity — Staff Category 2) Dr Wasiu G Balogun— Postdoc Category Incredible work and well deserved! 👏 #PittPsych #Pittresearchday #ResearchExcellence